Usefulness of the TIMI risk index in predicting short- and long-term mortality in patients with acute coronary syndromes

Leonard Ilkhanoff, Christopher J. O'Donnell, Carlos A. Camargo, T. David O'Halloran, Robert P. Giugliano, Donald M. Lloyd-Jones*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

In a cohort of 710 patients with acute coronary syndromes (ACSs), we demonstrated that the Thrombolysis In Myocardial Infarction Risk Index - a predictor of 30-day mortality in clinical trial patients with ST-elevation myocardial infarction (STEMI) - is a strong predictor of short- and long-term mortality with good discrimination ability (c statistics 0.77 to 0.79) among all subtypes of ACSs (STEMI, non-STEMI, and unstable angina pectoris). These results verify the utility of the Risk Index in unselected patients with STEMI, broaden its application to other types of ACSs, and extend its utility to stratification of long-term mortality risk.

Original languageEnglish (US)
Pages (from-to)773-777
Number of pages5
JournalAmerican Journal of Cardiology
Volume96
Issue number6
DOIs
StatePublished - Sep 15 2005

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Usefulness of the TIMI risk index in predicting short- and long-term mortality in patients with acute coronary syndromes'. Together they form a unique fingerprint.

Cite this